Skip to main content
Clinical Trials/NCT02419573
NCT02419573
Completed
Not Applicable

Pragmatic Trial of Airway Management in Out-of-Hospital Cardiac Arrest

University of Alabama at Birmingham6 sites in 1 country3,004 target enrollmentDecember 1, 2015
ConditionsCardiac Arrest

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Arrest
Sponsor
University of Alabama at Birmingham
Enrollment
3004
Locations
6
Primary Endpoint
Number of Patients Alive at 72 Hours After Episode.
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The primary objective of the trial is to determine if 72-hour survival after out-of-hospital cardiac arrest (OHCA) is improved with initial endotracheal intubation (ETI) over initial laryngeal tube (LT) airway management strategies.

Detailed Description

The primary objective of the trial is to determine if 72-hour survival after out-of-hospital cardiac arrest (OHCA) is improved with initial endotracheal intubation (ETI) over initial laryngeal tube (LT) airway management strategies. The null hypothesis is that 72-hour survival is similar between primary Laryngeal Tube (LT) SGA and primary ETI airway management strategies. Evaluated secondary outcomes will include return of spontaneous circulation, survival to hospital discharge, neurologically intact survival at hospital discharge, airway management performance, and clinical adverse events.

Registry
clinicaltrials.gov
Start Date
December 1, 2015
End Date
December 1, 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Henry E. Wang, MD, MS

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Out-of-hospital cardiac arrest (OHCA)
  • Adult (age ≥18 years or per local interpretation)
  • Non-traumatic etiology
  • Initiation of ventilatory support (e.g., bag-valve-mask device, non-rebreather mas, etc.)

Exclusion Criteria

  • Known pregnant women
  • Known prisoners
  • Major facial trauma (visible major deformity, copious oral bleeding, etc)
  • Major bleeding or exsanguination (e.g., major upper or lower GI bleed, visceral perforation, major uncontrolled bleeding from laceration or injury)
  • Patient receiving initial care by a non-PART participating EMS agency capable of performing ETI, LT, or other advanced airway management
  • Patients with ET tube, LT or other advanced airway device inserted prior to participating EMS agency arrival (e.g., inserted by healthcare facility personnel)
  • Patients with a pre-existing tracheostomy
  • Obvious asphyxial cardiac arrest (e.g., choking, foreign body aspiration, angioedema, epiglottitis, trauma to mouth and face, etc.)
  • Patients with a left ventricular assist device (LVAD) or total artificial heart (TAH)
  • Patients with pre-existing written "do-not-attempt-resuscitation" (DNAR) orders

Outcomes

Primary Outcomes

Number of Patients Alive at 72 Hours After Episode.

Time Frame: 72 hours

Number of patient alive at 72 hours after episode.

Secondary Outcomes

  • Return of Spontaneous Circulation (ROSC)(Patients will be followed from the time of the CA until death or ROSC whichever occurs first. The time frame for this secondary outcome may vary from minutes to hours, but is not expected to last longer than 12 hours.)
  • Number of Patients Alive at Hospital Discharge(From enrollment through end of hospital course. Maximum time interval not specified. Maximum time interval observed in study was 138 days.)
  • Number of Patients With Favorable Neurologic Status on Hospital Discharge(From enrollment through end of hospital course.)

Study Sites (6)

Loading locations...

Similar Trials